| Predicted Trait | |
| Reported Trait | Rheumatoid arthritis |
| Mapped Trait(s) | rheumatoid arthritis (EFO_0000685) |
| Score Construction | |
| PGS Name | metaPGS_RA |
| Development Method | |
| Name | Pruning and Thresholding (P+T) |
| Parameters | r2 threshold = 0.2; p-value threshold = 3e-03; variants were restricted to the top 5% score of IMPACT annotation (CD4+T T-bet); rare variants were excluded (<1% AF in EUR of 1KG phase 3). |
| Variants | |
| Original Genome Build | GRCh37 |
| Number of Variants | 2,575 |
| Effect Weight Type | beta |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000357 |
| Citation (link to publication) | Ishigaki K et al. Nat Genet (2022) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | |
| PGS Evaluation | |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
| — | [
|
European, East Asian, African unspecified, South Asian, Greater Middle Eastern (Middle Eastern, North African or Persian) | BBJ |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM014915 | PSS009927| Multi-ancestry (including European)| 7,460 individuals |
PGP000357 | Ishigaki K et al. Nat Genet (2022) |
Reported Trait: Rheumatoid arthritis | — | AUROC: 0.65 | Liability R2: 0.054 | Sex, Genotype PCs | Performance metrics are the mean values across eave-one-cohort-out cross-validation folds |
| PPM014916 | PSS009930| European Ancestry| 3,887 individuals |
PGP000357 | Ishigaki K et al. Nat Genet (2022) |
Reported Trait: Rheumatoid arthritis | — | AUROC: 0.66 | Liability R2: 0.059 | Sex, Genotype PCs | Performance metrics are the mean values across eave-one-cohort-out cross-validation folds |
| PPM014917 | PSS009929| East Asian Ancestry| 21,704 individuals |
PGP000357 | Ishigaki K et al. Nat Genet (2022) |
Reported Trait: Rheumatoid arthritis | — | AUROC: 0.66 | Liability R2: 0.057 | Sex, Genotype PCs | Performance metrics are the mean values across eave-one-cohort-out cross-validation folds |
| PPM014918 | PSS009928| Multi-ancestry (excluding European)| 1,304 individuals |
PGP000357 | Ishigaki K et al. Nat Genet (2022) |
Reported Trait: Rheumatoid arthritis | — | AUROC: 0.59 | Liability R2: 0.018 | Sex, Genotype PCs | Performance metrics are the mean values across eave-one-cohort-out cross-validation folds |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS009927 | — | — | [
|
— | European, East Asian, African unspecified, South Asian, Greater Middle Eastern (Middle Eastern, North African or Persian) | — | BBJ | Average Cohort Size. Overlaps GWAS Cohorts; however performance metrics are derived using a leave-one-cohort-out cross-validation to minimize overlap |
| PSS009928 | — | — | [
|
— | African unspecified, South Asian, Greater Middle Eastern (Middle Eastern, North African or Persian) | — | NR | Average Cohort Size. Overlaps GWAS Cohorts; however performance metrics are derived using a leave-one-cohort-out cross-validation to minimize overlap |
| PSS009929 | — | — | [
|
— | East Asian | — | BBJ | Average Cohort Size. Overlaps GWAS Cohorts; however performance metrics are derived using a leave-one-cohort-out cross-validation to minimize overlap |
| PSS009930 | — | — | [
|
— | European | — | NR | Average Cohort Size. Overlaps GWAS Cohorts; however performance metrics are derived using a leave-one-cohort-out cross-validation to minimize overlap |